NCT02786043View on ClinicalTrials.gov

PK Study to Evaluate the Effect of PLC on Healthy Chinese Subjects by Multiple-doses

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

November 30, 2015

Study Completion Date

January 31, 2016

Conditions
Peripheral Arterial Diseases
Interventions
DRUG

Propionyl-L-Carnitine Hydrochloride

1g twice a day on first 4 days and 1g/ day on day 5 during Phase III

Sponsors
All Listed Sponsors
lead

Lee's Pharmaceutical Limited

INDUSTRY